Updated hepatitis D seroprevalence among HBsAg-positive persons aged ≥6 years in the United States, National Health and Nutrition Examination Survey, 2007‒2018
To validate the accuracy of previously published US seroprevalence estimates for hepatitis D virus (HDV) antibody, we retested National Health and Nutrition Examination Survey samples from 2007‒2018 using a different assay. We found the HDV seroprevalence among hepatitis B surface antigen positive participants aged ≥6 years to be 1.26%.
Authors
- Ruth Jiles (ORCID: https://orcid.org/0000-0002-7132-4008)
- David L. Thomas (ORCID: https://orcid.org/0000-0002-0749-925X)
- Amy L. Sandul (ORCID: https://orcid.org/0000-0002-7623-8408)
- Eshan U. Patel (ORCID: https://orcid.org/0000-0003-2174-5004)
- Eyasu H. Teshale (ORCID: https://orcid.org/0000-0001-5244-8251)
- Saleem Kamili (ORCID: https://orcid.org/0000-0002-7984-9044)
- Asiya Seema Chida (ORCID: https://orcid.org/0000-0002-5730-1934)
- Shannon M. Casillas (ORCID: https://orcid.org/0000-0001-7819-910X)
- Jan Drobeniuc (ORCID: https://orcid.org/0000-0002-0735-8115)
- Aaron A.R. Tobian
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2026-04-22
- DOI
- https://doi.org/10.1093/cid/ciag274
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00